development of novel solutions to clinical problems
It occurred to me that in my position performing, directing and reviewing market research on a global scale that it would be worthwhile to highlight recent insights that have come to me regarding the global medical technology market. Some of these insights, of course, may only be meaningful to me (and those who have a [...]
Medtech financings year to date (through August 2010) now stand at $2.57 billion, about 17% ahead of financings by this date in 2009. August 2010 financing came in at a modest $267 million, following the year-high month of July which had financings of $518 million. If the remainder of 2010 follows a typical course, total [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
(See PRLog press release at link.) As well established as the practices are for the management of types 1 and 2 diabetes, a raft of new technologies, from modest to radical, are steadily entering clinical practice and the industry, according to a new report from MedMarket Diligence. FOR IMMEDIATE RELEASE PRLog (Press Release) – Aug [...]
Below is a list of technologies in development at recently identified medtech startups during May to July: Single incision laparoscopic surgery and natural orifice transluminal endoscopic surgery. Medical device development company. Surgical instrumentation and osteogenic biomaterials for spine surgery. Clinical diagnostics including a noninvasive prenatal diagnostics. Laparoscopic surgical instrumentation. Ultrasonic breast cancer detection device. Technologies for [...]
With medical technology financing driven way over the top by the $151.5 million financing by Devicor Medical Products (acquirer of J&J's Ethicon Endo-Surgery breast-care business), the July 2010 total hit a year high-to-date $518.3 million. See individual financings below. Replication Medical, Inc., has raised $1.1 million in funding according to a regulatory filing (implantable hydrogel [...]
Technologies that destroy tissue for therapeutic benefit are collectively known as ablation technologies. By a wide range of energy types or other mechanical methods, they are used to destroy, excise or otherwise treat tissue for therapeutic benefit, from the radiation of cancer, the destruction of the endometrial lining of the uterus causing endometriosis, the creation [...]
Medtech financings for the month of July are on track to likely pass $500 million, driven primarily by the $151 million funding by Devicor Medical Products, who recently acquired the breast-care business of J&J's Ethicon Endo-Surgery unit. Other significant financings contributing to the total include $60 million for TriVascular, $45 million for Theranos, $40 million [...]
Medical technology financings for July 2010 are off to a modest start. As of July 7, total medtech financings stood at $97.3 million, driven by DFIne ($36.2MM), Uptake Medical ($17.5MM), and Neoprobe ($14MM). For a running list of July 2010 financings, see link. bookmark to
Historically, closure of surgical incisions has been achieved through an ever-evolving portfolio of suture, staple and tape products. In the early 1990s, physicians involved in sports medicine were the first non-military practitioners to adopt cyanoacrylate glues to achieve immediate closure of small cuts and lacerations, and an awareness of this opportunity developed in large multinational [...]
Contact:
